BIOMAT Database Logo BIOMAT Database Logo

Anti-idiotypic humoral and cellular responses to antibody to hepatitis B surface antigen in hepatitis B viral infections. 1988

S Rath, and V Bal, and B J Mohite, and V Haridas, and S R Naik, and S A Kamat, and A J Zuckerman, and R S Kamat
Department of Clinical Pathology, Haffikine Institute, Bombay, India.

In order to investigate regulatory significance of humoral and cellular responses to the idiotypic (Id) determinants on the antibody to hepatitis B surface antigen (anti-HBs), they were studied in acute hepatitis B and in chronic HBV infection. The results were compared with humoral and cellular responses of the same patients to hepatitis B surface antigen (HBsAg). In acute hepatitis B, the responses to HBsAg, were delayed until 3-4 weeks after the onset of clinical symptoms. However, the leucocyte migration inhibition (LMI) and the lymphocyte transformation (LTT) responses to affinity purified anti-HBs were found to be evolved very early in the course of acute hepatitis B, though anti-Id antibodies were absent. The majority of chronic HBV carriers showed a poor humoral and cellular response to HBsAg. Ten out of 38 chronic carriers showed anti-Id antibodies which recognized a major cross-reactive idiotype (CRI) on the anti-HBs molecule. Twenty-five out of 38 chronic carriers also showed LMI response to the Id determinants on the anti-HBs. LMI response induced by anti-HBs could be blocked by a specific Balb/c anti-Id antibody which also recognized the CRI. Thus, in both acute and chronic HBV infections, the anti-Id humoral and cellular responses correlated with poor humoral and cellular responses to HBsAg, indicating regulatory significance.

UI MeSH Term Description Entries
D007130 Immunoglobulin Idiotypes Unique genetically-controlled determinants present on ANTIBODIES whose specificity is limited to a single group of proteins (e.g., another antibody molecule or an individual myeloma protein). The idiotype appears to represent the antigenicity of the antigen-binding site of the antibody and to be genetically codetermined with it. The idiotypic determinants have been precisely located to the IMMUNOGLOBULIN VARIABLE REGION of both immunoglobin polypeptide chains. Idiotypes, Immunoglobulin,Ig Idiotypes,Idiotype, Ig,Idiotype, Immunoglobulin,Idiotypes, Ig,Ig Idiotype,Immunoglobulin Idiotype
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D002464 Cell Migration Inhibition Phenomenon of cell-mediated immunity measured by in vitro inhibition of the migration or phagocytosis of antigen-stimulated LEUKOCYTES or MACROPHAGES. Specific CELL MIGRATION ASSAYS have been developed to estimate levels of migration inhibitory factors, immune reactivity against tumor-associated antigens, and immunosuppressive effects of infectious microorganisms. Chemotaxis Inhibition,Chemotaxis Inhibitions,Inhibition, Chemotaxis,Inhibitions, Chemotaxis
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Rath, and V Bal, and B J Mohite, and V Haridas, and S R Naik, and S A Kamat, and A J Zuckerman, and R S Kamat
Enhancement of antibody production to hepatitis B surface antigen by anti-idiotypic antibody.
September 1986, Gut,
S Rath, and V Bal, and B J Mohite, and V Haridas, and S R Naik, and S A Kamat, and A J Zuckerman, and R S Kamat
Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
December 1996, Hepatology (Baltimore, Md.),
S Rath, and V Bal, and B J Mohite, and V Haridas, and S R Naik, and S A Kamat, and A J Zuckerman, and R S Kamat
Humoral and cellular immune responses by normal individuals to hepatitis B surface antigen vaccination.
March 1988, Clinical and experimental immunology,
S Rath, and V Bal, and B J Mohite, and V Haridas, and S R Naik, and S A Kamat, and A J Zuckerman, and R S Kamat
Passively acquired antibody to hepatitis B surface antigen. Pitfall in evaluating immunity to hepatitis B viral infections.
May 1989, Archives of pathology & laboratory medicine,
S Rath, and V Bal, and B J Mohite, and V Haridas, and S R Naik, and S A Kamat, and A J Zuckerman, and R S Kamat
Platycodin D2 improves specific cellular and humoral responses to hepatitis B surface antigen in mice.
January 2010, Chemistry & biodiversity,
S Rath, and V Bal, and B J Mohite, and V Haridas, and S R Naik, and S A Kamat, and A J Zuckerman, and R S Kamat
Cellular and humoral immunity to hepatitis-B surface antigen in active chronic hepatitis.
March 1975, British medical journal,
S Rath, and V Bal, and B J Mohite, and V Haridas, and S R Naik, and S A Kamat, and A J Zuckerman, and R S Kamat
Anti-idiotypic antibody vaccine for type B viral hepatitis in chimpanzees.
April 1986, Science (New York, N.Y.),
S Rath, and V Bal, and B J Mohite, and V Haridas, and S R Naik, and S A Kamat, and A J Zuckerman, and R S Kamat
In vitro antigen-induced antibody responses to hepatitis B surface antigen in man. Kinetic and cellular requirements.
October 1984, The Journal of clinical investigation,
S Rath, and V Bal, and B J Mohite, and V Haridas, and S R Naik, and S A Kamat, and A J Zuckerman, and R S Kamat
Distinct regulation of humoral and cellular immunities to hepatitis B surface antigen.
November 1990, Immunology,
S Rath, and V Bal, and B J Mohite, and V Haridas, and S R Naik, and S A Kamat, and A J Zuckerman, and R S Kamat
Monoclonal anti-idiotypic antibodies as surrogates for hepatitis B surface antigen.
January 1986, International reviews of immunology,
Copied contents to your clipboard!